THE CURRENT BUSINESS FOCUS
The focus of current business activity is on the diagnosis of polyneuropathy (PNP). They can have different causes. It is generally assumed that two-thirds of all polyneuropathies are caused by diabetes or alcohol abuse.
The other third is caused by toxic substances such as arsenic, bismuth, lead or carbon monoxide.
PNP is a widespread disease – as mentioned above. mostly as a result of diabetes mellitus. Between 3 and 6% of the German population are currently affected by it – and the trend is rising.
In Germany there are about 8 million people with diabetes. The age pyramid is partly responsible for this disorder of metabolism and its increasing number of cases. The increasing malnutrition also contributes to this.
The mortality rate due to diabetes and its sequelae is about 2% in Germany.
We work closely with freelancers and external consultants to develop new products.
The production of the instruments is outsourced. Quality control and management takes place at the company headquarters.
During the design and development of sophisticated instruments – e.g. the “Neuroscreen” device line – cooperation with external experts and multipliers is indispensable. This is necessary with regard to intended examination procedures as well as to the evaluation of the diagnostic value of a new tool.
This is another reason why we cooperate with the DFI, the University Hospital Düsseldorf and other renowned institutes.